The growth of the market is driven by the factors such as, increasing prevalence of irritable bowel syndrome and associated conditions, and increasing numbers of FDA approvals & drug developments. On the other hand, limited number of product availability and treatment inefficiency is likely to restraint the growth of market during the forecast years.
Irritable Bowel Syndrome is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.
Register for a free trial today and gain instant access to our market research reports at https://www.businessmarketinsights.com/TIPRE00009741/request-trial
Top Companies are:
- Ironwood Pharmaceuticals, Inc.
- Allergan Plc.
- Sebela Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Alfasigma S.p.A.
- Astellas Pharma Inc.
- Synthetic Biologics, Inc.
- Bausch + Lomb Incorporated
- Lannett Company Inc.
Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. According to data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated have 25% severe IBS. Many people don’t recognize IBS symptoms. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are some of the risk factors which are causing irritable bowel syndrome. These factors are projected to accelerate the rate of prevalence of irritable bowel syndrome across the globe. For instance, according to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of irritable bowel syndrome is likely to boost the US irritable bowel syndrome treatment market during the forecast period.
In order to cope up against irritable bowel syndrome in the country, the companies involved in the drug development for irritable bowel syndrome are taking constructive steps to implement awareness programs with an aim to spread awareness amongst the populations. For instance, in 2018, the collaboration of Allergan PLC and Ironwood launched an Interactive Digital Destination platform to encourage sufferers to get educated and take action. Such initiatives are also anticipated to drive the demand for irritable bowel syndrome treatment market in US.
The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.
Business Market Insights provides affordable subscription with pay as per requirement at https://www.businessmarketinsights.com/TIPRE00009741/checkout/basic/single/monthly
(30-day subscription plans prove to be very cost-effective with no compromise on the quality of reports)
Benefits with Business Market Insights
- One Stop Platform to All the Market Insight Needs
- Avoid Long Purchase Procedures
- Fast and Easy Access
- Cloud-Based Platform
- News Updates
- Ask the Analyst Support
- Pay Monthly Subscription and Access All You Want
- No Compulsion for Yearly Subscription
- Reports Read or Download Access
- Monthly New Reports Added
- Affordable Product, Pay as Per Requirement
About Business Market Insights
Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.
For Subscription contact
Business Market Insights